Susquehanna Portfolio Strategies’s CytomX Therapeutics CTMX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$226K	Buy	+99,410	New	+$226K	﹤0.01%	784
2024 Q1	–	Sell	-31,869	Closed	-$49.4K	–	824
2023 Q4	$49.4K	Buy	+31,869	New	+$49.4K	﹤0.01%	987